Cecilia Ahlin

637 total citations
22 papers, 497 citations indexed

About

Cecilia Ahlin is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cecilia Ahlin has authored 22 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cecilia Ahlin's work include Breast Cancer Treatment Studies (9 papers), Cancer-related Molecular Pathways (9 papers) and Advanced Breast Cancer Therapies (4 papers). Cecilia Ahlin is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Cancer-related Molecular Pathways (9 papers) and Advanced Breast Cancer Therapies (4 papers). Cecilia Ahlin collaborates with scholars based in Sweden, Finland and United Kingdom. Cecilia Ahlin's co-authors include Carl Blomqvist, Marie-Louise Fjällskog, Rose‐Marie Amini, Bengt Sorbe, Karin Jirström, Marit Holmqvist, Lars Holmberg, Kirsimari Aaltonen, Heli Nevanlinna and Mårten Fernö and has published in prestigious journals such as PLoS ONE, Cancer Research and British Journal of Cancer.

In The Last Decade

Cecilia Ahlin

22 papers receiving 491 citations

Peers

Cecilia Ahlin
Shivakumar Subramaniyam United States
Valentina Tuninetti Italy
Grażyna Pasz‐Walczak Poland
Nicole N. Esposito United States
Teiji Umemura Japan
Paul Thiruchelvam United Kingdom
Piera Gargiulo Italy
Seyran Yiğit Türkiye
B Gairard France
S A Bartow United States
Shivakumar Subramaniyam United States
Cecilia Ahlin
Citations per year, relative to Cecilia Ahlin Cecilia Ahlin (= 1×) peers Shivakumar Subramaniyam

Countries citing papers authored by Cecilia Ahlin

Since Specialization
Citations

This map shows the geographic impact of Cecilia Ahlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Ahlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Ahlin more than expected).

Fields of papers citing papers by Cecilia Ahlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Ahlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Ahlin. The network helps show where Cecilia Ahlin may publish in the future.

Co-authorship network of co-authors of Cecilia Ahlin

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Ahlin. A scholar is included among the top collaborators of Cecilia Ahlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Ahlin. Cecilia Ahlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grönberg, Malin, et al.. (2017). Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer. PLoS ONE. 12(4). e0176059–e0176059. 9 indexed citations
2.
Ahlin, Cecilia, et al.. (2017). Assessing nursing students' knowledge and skills in performing venepuncture and inserting peripheral venous catheters. Nurse Education in Practice. 23. 8–14. 25 indexed citations
3.
Ahlin, Cecilia, et al.. (2017). High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers. Breast Cancer Research and Treatment. 164(3). 667–678. 67 indexed citations
4.
5.
Ziółkowski, Piotr, Cecilia Ahlin, Anil Agrawal, et al.. (2015). Nuclear osteopontin-c is a prognostic breast cancer marker. British Journal of Cancer. 112(4). 729–738. 38 indexed citations
6.
Ahlin, Cecilia, et al.. (2014). Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control study. Acta Oncologica. 54(4). 543–549. 12 indexed citations
7.
8.
Sorbe, Bengt, et al.. (2014). Natural history of recurrences in endometrial carcinoma. Oncology Letters. 8(4). 1800–1806. 30 indexed citations
9.
10.
Ahlin, Cecilia, Marit Holmqvist, Lars Holmberg, et al.. (2012). Inflammatory cells in node-negative breast cancer. Acta Oncologica. 51(5). 680–686. 15 indexed citations
11.
Nilsson, Cecilia, Ida Johansson, Cecilia Ahlin, et al.. (2012). Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact. Acta Oncologica. 52(1). 102–109. 41 indexed citations
12.
Nilsson, Cecilia, Anthoula Koliadi, Ida Johansson, et al.. (2012). High proliferation is associated with inferior outcome in male breast cancer patients. Modern Pathology. 26(1). 87–94. 21 indexed citations
13.
Sorbe, Bengt, et al.. (2012). A study of serum biomarkers associated with relapse of cervical cancer.. PubMed. 32(11). 4913–22. 5 indexed citations
14.
Strand, Carina, Cecilia Ahlin, Pär‐Ola Bendahl, et al.. (2011). Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancer. Breast Cancer Research and Treatment. 131(1). 33–40. 13 indexed citations
15.
Wegman, Pia, Cecilia Ahlin, & Bengt Sorbe. (2010). Genetic Alterations in the K-Ras Gene Influence the Prognosis in Patients With Cervical Cancer Treated by Radiotherapy. International Journal of Gynecological Cancer. 21(1). 86–91. 26 indexed citations
16.
Koliadi, Anthoula, Cecilia Ahlin, Marit Holmqvist, et al.. (2009). Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population‐based lymph node negative breast cancer cohort. International Journal of Cancer. 127(4). 961–967. 51 indexed citations
17.
Koliadi, Anthoula, et al.. (2009). Cyclin B as a prognostic factor in low-risk node negative breast cancer.. Cancer Research. 69(2_Supplement). 4161–4161. 2 indexed citations
18.
Ahlin, Cecilia, et al.. (2008). Aberrant expression of cyclin E in low-risk node negative breast cancer. Acta Oncologica. 47(8). 1539–1545. 1 indexed citations
19.
Ahlin, Cecilia, et al.. (2007). Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut‐off values?. Histopathology. 51(4). 491–498. 57 indexed citations
20.
Aaltonen, Kirsimari, Cecilia Ahlin, Rose‐Marie Amini, et al.. (2006). Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides. British Journal of Cancer. 94(11). 1697–1702. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shivakumar Subramaniyam Breakdown of academic impact, for papers by Valentina Tuninetti Breakdown of academic impact, for papers by Grażyna Pasz‐Walczak Breakdown of academic impact, for papers by Nicole N. Esposito Breakdown of academic impact, for papers by Teiji Umemura Breakdown of academic impact, for papers by Paul Thiruchelvam Breakdown of academic impact, for papers by Piera Gargiulo Breakdown of academic impact, for papers by Seyran Yiğit Breakdown of academic impact, for papers by B Gairard Breakdown of academic impact, for papers by S A Bartow
Rankless by CCL
2026